Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Epoetin Alfa Biosimilar Treatment for Chemotherapy-Induced Anemia in Current Oncology and Hematology Practice: An Iron Supplementation Subanalysis of the Synergy Study

Florian Scotté, Kamel Laribi, Christian Gisselbrecht, Dominique Spaeth, Emna Kasdaghli, MD, Hélène Albrand, MD, Eric Leutenegger, Isabelle Ray-Coquard

Blood (2015) 126 (23): 3363.

https://doi.org/10.1182/blood.V126.23.3363.3363

Published: 2015

Journal Articles

Treatment of Chemotherapy-Induced Anemia Using Epoetin Alfa Biosimilar for Patients with Lymphoma and Myeloma: The Synergy Study

Florian Scotté, Kamel Laribi, Christian Gisselbrecht, Dominique Spaeth, Emna Kasdaghli, MD, Hélène Albrand, MD, Eric Leutenegger, Isabelle Ray-Coquard

Blood (2015) 126 (23): 952.

https://doi.org/10.1182/blood.V126.23.952.952

Published: 2015

Journal Articles

Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients

Jean François Rossi, Laurence Laurier, III, Jean-Louis Misset, Dominique Spaeth, F. Uwer, Pierre Soubeyran, Remy Largiller, Jean-Philippe Metges, Jean- Yves Blay, Michel Attal, Thierry Facon, Olivier Hermine, Roland Bugat, Jean-Philippe Spano, Laurent Cals, Hervé Cure, Dan Atlan, Mario Gjoklaj

Blood (2008) 112 (11): 1309.

https://doi.org/10.1182/blood.V112.11.1309.1309

Published: 2008

Journal Articles

Efficacy and Safety of Once Weekly Epoetin Beta 30 000 IU in 691 Patients with Solid or Lymphoid Malignancies Receiving Chemotherapy: Results from the NAUTICA Study.

Dominique Spaeth, Gilles Salles, Thierry Facon, Reda Garidi, Francois Pichon, Ghandi Damaj, Loic Bergougnoux

Blood (2006) 108 (11): 3758.

https://doi.org/10.1182/blood.V108.11.3758.3758

Published: 2006

Journal Articles

Efficacy and Safety of Epoetin beta 30 000 IU Once Weekly in Anemic Patients with Non-Myeloid Malignancies Receiving Chemotherapy.

Gandhi Damaj, Reda Garidi, Philippe Rodon, Dominique Bordessoule, Dominique Spaeth, Paola Fiorentini, Loïc Bergougnoux

Blood (2005) 106 (11): 4281.

https://doi.org/10.1182/blood.V106.11.4281.4281

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Epoetin Alfa Biosimilar Treatment for Chemotherapy-Induced Anemia in Current Oncology and Hematology Practice: An Iron Supplementation Subanalysis of the Synergy Study

Treatment of Chemotherapy-Induced Anemia Using Epoetin Alfa Biosimilar for Patients with Lymphoma and Myeloma: The Synergy Study

Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients

Efficacy and Safety of Once Weekly Epoetin Beta 30 000 IU in 691 Patients with Solid or Lymphoid Malignancies Receiving Chemotherapy: Results from the NAUTICA Study.

Efficacy and Safety of Epoetin beta 30 000 IU Once Weekly in Anemic Patients with Non-Myeloid Malignancies Receiving Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Update search

Epoetin Alfa Biosimilar Treatment for Chemotherapy-Induced Anemia in Current Oncology and Hematology Practice: An Iron Supplementation Subanalysis of the Synergy Study

Treatment of Chemotherapy-Induced Anemia Using Epoetin Alfa Biosimilar for Patients with Lymphoma and Myeloma: The Synergy Study

Prospective Multicenter Study for Evaluating Cognitive Disorders in Hematology-Oncology: A Pilot Study of 118 Patients

Efficacy and Safety of Once Weekly Epoetin Beta 30 000 IU in 691 Patients with Solid or Lymphoid Malignancies Receiving Chemotherapy: Results from the NAUTICA Study.

Efficacy and Safety of Epoetin beta 30 000 IU Once Weekly in Anemic Patients with Non-Myeloid Malignancies Receiving Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only